0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Virus Vaccine (H1N1) Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-23N7548
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Influenza Virus Vaccine H1N1 Market Insights and Forecast to 2028

Global Influenza Virus Vaccine (H1N1) Market Insights and Forecast to 2028

Code: QYRE-Auto-23N7548
Report
May 2022
110 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.
Market Analysis and Insights: Global Influenza Virus Vaccine (H1N1) Market

Due to the COVID-19 pandemic, the global Influenza Virus Vaccine (H1N1) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Intramuscular Vaccine accounting for % of the Influenza Virus Vaccine (H1N1) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While 3 To 10 Years Old segment is altered to an % CAGR throughout this forecast period.
China Influenza Virus Vaccine (H1N1) market size is valued at US$ million in 2021, while the US and Europe Influenza Virus Vaccine (H1N1) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Influenza Virus Vaccine (H1N1) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Influenza Virus Vaccine (H1N1) include CSL, NVS(Novartis), Sanofi Pasteur, Medimmune, GSK, Baxter, Beijing Kexing Bio-Vaccine, Hualan Bio-Vaccine and Changchun Changsheng Bio-Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Influenza Virus Vaccine (H1N1) Scope and Segment
Influenza Virus Vaccine (H1N1) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Influenza Virus Vaccine (H1N1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Intramuscular Vaccine
Nasal Spray Vaccine

Segment by Application

3 To 10 Years Old
10 To 18 Years Old
Above 18 Years Old
Other

BY COMPANY

CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Influenza Virus Vaccine (H1N1) Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Market by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Virus Vaccine (H1N1) Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Virus Vaccine (H1N1) Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Virus Vaccine (H1N1) Sales by Region
2.4.1 Global Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Virus Vaccine (H1N1) by Region (2023-2028)
2.5 Global Influenza Virus Vaccine (H1N1) Revenue by Region
2.5.1 Global Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022)
2.5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers
3.1.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Virus Vaccine (H1N1) in 2021
3.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers
3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2021
3.3 Global Influenza Virus Vaccine (H1N1) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Virus Vaccine (H1N1) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Virus Vaccine (H1N1) Sales by Type
4.1.1 Global Influenza Virus Vaccine (H1N1) Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Virus Vaccine (H1N1) Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
4.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type
4.2.1 Global Influenza Virus Vaccine (H1N1) Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Virus Vaccine (H1N1) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Virus Vaccine (H1N1) Price by Type
4.3.1 Global Influenza Virus Vaccine (H1N1) Price by Type (2017-2022)
4.3.2 Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza Virus Vaccine (H1N1) Sales by Application
5.1.1 Global Influenza Virus Vaccine (H1N1) Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Virus Vaccine (H1N1) Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application
5.2.1 Global Influenza Virus Vaccine (H1N1) Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Virus Vaccine (H1N1) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Virus Vaccine (H1N1) Price by Application
5.3.1 Global Influenza Virus Vaccine (H1N1) Price by Application (2017-2022)
5.3.2 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza Virus Vaccine (H1N1) Market Size by Type
6.1.1 North America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
6.1.2 North America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
6.2 North America Influenza Virus Vaccine (H1N1) Market Size by Application
6.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
6.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
6.3 North America Influenza Virus Vaccine (H1N1) Market Size by Country
6.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
6.3.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Virus Vaccine (H1N1) Market Size by Type
7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
7.2 Europe Influenza Virus Vaccine (H1N1) Market Size by Application
7.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
7.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
7.3 Europe Influenza Virus Vaccine (H1N1) Market Size by Country
7.3.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
7.3.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Type
8.1.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Application
8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region
8.3.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Virus Vaccine (H1N1) Market Size by Type
9.1.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
9.1.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
9.2 Latin America Influenza Virus Vaccine (H1N1) Market Size by Application
9.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
9.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
9.3 Latin America Influenza Virus Vaccine (H1N1) Market Size by Country
9.3.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
9.3.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Type
10.1.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Application
10.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Country
10.3.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 NVS(Novartis)
11.2.1 NVS(Novartis) Corporation Information
11.2.2 NVS(Novartis) Overview
11.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NVS(Novartis) Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Medimmune
11.4.1 Medimmune Corporation Information
11.4.2 Medimmune Overview
11.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medimmune Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medimmune Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Overview
11.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Recent Developments
11.7 Beijing Kexing Bio-Vaccine
11.7.1 Beijing Kexing Bio-Vaccine Corporation Information
11.7.2 Beijing Kexing Bio-Vaccine Overview
11.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Kexing Bio-Vaccine Recent Developments
11.8 Hualan Bio-Vaccine
11.8.1 Hualan Bio-Vaccine Corporation Information
11.8.2 Hualan Bio-Vaccine Overview
11.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hualan Bio-Vaccine Recent Developments
11.9 Changchun Changsheng Bio-Technology
11.9.1 Changchun Changsheng Bio-Technology Corporation Information
11.9.2 Changchun Changsheng Bio-Technology Overview
11.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Changchun Changsheng Bio-Technology Recent Developments
11.10 Beijing Tiantan Bio-Products
11.10.1 Beijing Tiantan Bio-Products Corporation Information
11.10.2 Beijing Tiantan Bio-Products Overview
11.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Beijing Tiantan Bio-Products Recent Developments
11.11 Jiangsu Yanshen Bio-Technology
11.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
11.11.2 Jiangsu Yanshen Bio-Technology Overview
11.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangsu Yanshen Bio-Technology Recent Developments
11.12 Zhejiang Tianyuan Bio-Pharmaceutical
11.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
11.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Overview
11.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
11.13 Dalian Yalifeng Bio-Pharmaceutical
11.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
11.13.2 Dalian Yalifeng Bio-Pharmaceutical Overview
11.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments
11.14 Sinopharm
11.14.1 Sinopharm Corporation Information
11.14.2 Sinopharm Overview
11.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sinopharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Virus Vaccine (H1N1) Industry Chain Analysis
12.2 Influenza Virus Vaccine (H1N1) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Virus Vaccine (H1N1) Production Mode & Process
12.4 Influenza Virus Vaccine (H1N1) Sales and Marketing
12.4.1 Influenza Virus Vaccine (H1N1) Sales Channels
12.4.2 Influenza Virus Vaccine (H1N1) Distributors
12.5 Influenza Virus Vaccine (H1N1) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Virus Vaccine (H1N1) Industry Trends
13.2 Influenza Virus Vaccine (H1N1) Market Drivers
13.3 Influenza Virus Vaccine (H1N1) Market Challenges
13.4 Influenza Virus Vaccine (H1N1) Market Restraints
14 Key Findings in The Global Influenza Virus Vaccine (H1N1) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Intramuscular Vaccine
    Table 3. Major Manufacturers of Nasal Spray Vaccine
    Table 4. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
    Table 7. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
    Table 8. Global Influenza Virus Vaccine (H1N1) Sales by Region (2023-2028) & (K Doses)
    Table 9. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2023-2028)
    Table 10. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)
    Table 12. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2023-2028)
    Table 14. Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers (2017-2022) & (K Doses)
    Table 15. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2017-2022)
    Table 16. Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2017-2022)
    Table 18. Influenza Virus Vaccine (H1N1) Price by Manufacturers (2017-2022) &(US$/Dose)
    Table 19. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2021)
    Table 21. Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Influenza Virus Vaccine (H1N1) Product Offered
    Table 23. Date of Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
    Table 26. Global Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
    Table 27. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2017-2022)
    Table 28. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2023-2028)
    Table 29. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2017-2022)
    Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2023-2028)
    Table 33. Influenza Virus Vaccine (H1N1) Price by Type (2017-2022) & (US$/Dose)
    Table 34. Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2023-2028) & (US$/Dose)
    Table 35. Global Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
    Table 36. Global Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
    Table 37. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2017-2022)
    Table 38. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2023-2028)
    Table 39. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2017-2022)
    Table 42. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2023-2028)
    Table 43. Influenza Virus Vaccine (H1N1) Price by Application (2017-2022) & (US$/Dose)
    Table 44. Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2023-2028) & (US$/Dose)
    Table 45. North America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
    Table 46. North America Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
    Table 47. North America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
    Table 50. North America Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
    Table 51. North America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
    Table 54. North America Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
    Table 55. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
    Table 58. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
    Table 59. Europe Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
    Table 62. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
    Table 63. Europe Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
    Table 66. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
    Table 67. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
    Table 70. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
    Table 71. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
    Table 74. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
    Table 75. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
    Table 78. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2023-2028) & (K Doses)
    Table 79. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
    Table 82. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
    Table 83. Latin America Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
    Table 86. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
    Table 87. Latin America Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
    Table 90. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
    Table 91. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
    Table 94. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2023-2028) & (K Doses)
    Table 95. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)
    Table 98. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2023-2028) & (K Doses)
    Table 99. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
    Table 102. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2023-2028) & (K Doses)
    Table 103. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2023-2028) & (US$ Million)
    Table 105. CSL Corporation Information
    Table 106. CSL Description and Major Businesses
    Table 107. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 108. CSL Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. CSL Recent Developments
    Table 110. NVS(Novartis) Corporation Information
    Table 111. NVS(Novartis) Description and Major Businesses
    Table 112. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 113. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. NVS(Novartis) Recent Developments
    Table 115. Sanofi Pasteur Corporation Information
    Table 116. Sanofi Pasteur Description and Major Businesses
    Table 117. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 118. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Sanofi Pasteur Recent Developments
    Table 120. Medimmune Corporation Information
    Table 121. Medimmune Description and Major Businesses
    Table 122. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 123. Medimmune Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Medimmune Recent Developments
    Table 125. GSK Corporation Information
    Table 126. GSK Description and Major Businesses
    Table 127. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 128. GSK Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. GSK Recent Developments
    Table 130. Baxter Corporation Information
    Table 131. Baxter Description and Major Businesses
    Table 132. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 133. Baxter Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Baxter Recent Developments
    Table 135. Beijing Kexing Bio-Vaccine Corporation Information
    Table 136. Beijing Kexing Bio-Vaccine Description and Major Businesses
    Table 137. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 138. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Beijing Kexing Bio-Vaccine Recent Developments
    Table 140. Hualan Bio-Vaccine Corporation Information
    Table 141. Hualan Bio-Vaccine Description and Major Businesses
    Table 142. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 143. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Hualan Bio-Vaccine Recent Developments
    Table 145. Changchun Changsheng Bio-Technology Corporation Information
    Table 146. Changchun Changsheng Bio-Technology Description and Major Businesses
    Table 147. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 148. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Changchun Changsheng Bio-Technology Recent Developments
    Table 150. Beijing Tiantan Bio-Products Corporation Information
    Table 151. Beijing Tiantan Bio-Products Description and Major Businesses
    Table 152. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 153. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Beijing Tiantan Bio-Products Recent Developments
    Table 155. Jiangsu Yanshen Bio-Technology Corporation Information
    Table 156. Jiangsu Yanshen Bio-Technology Description and Major Businesses
    Table 157. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 158. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Jiangsu Yanshen Bio-Technology Recent Developments
    Table 160. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
    Table 161. Zhejiang Tianyuan Bio-Pharmaceutical Description and Major Businesses
    Table 162. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 163. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments
    Table 165. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
    Table 166. Dalian Yalifeng Bio-Pharmaceutical Description and Major Businesses
    Table 167. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 168. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Dalian Yalifeng Bio-Pharmaceutical Recent Developments
    Table 170. Sinopharm Corporation Information
    Table 171. Sinopharm Description and Major Businesses
    Table 172. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 173. Sinopharm Influenza Virus Vaccine (H1N1) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Sinopharm Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Influenza Virus Vaccine (H1N1) Distributors List
    Table 178. Influenza Virus Vaccine (H1N1) Customers List
    Table 179. Influenza Virus Vaccine (H1N1) Market Trends
    Table 180. Influenza Virus Vaccine (H1N1) Market Drivers
    Table 181. Influenza Virus Vaccine (H1N1) Market Challenges
    Table 182. Influenza Virus Vaccine (H1N1) Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Virus Vaccine (H1N1) Product Picture
    Figure 3. Global Influenza Virus Vaccine (H1N1) Market Share by Type in 2021 & 2028
    Figure 3. Intramuscular Vaccine Product Picture
    Figure 4. Nasal Spray Vaccine Product Picture
    Figure 5. Global Influenza Virus Vaccine (H1N1) Market Share by Application in 2021 & 2028
    Figure 6. 3 To 10 Years Old
    Figure 7. 10 To 18 Years Old
    Figure 8. Above 18 Years Old
    Figure 9. Other
    Figure 10. Influenza Virus Vaccine (H1N1) Report Years Considered
    Figure 11. Global Influenza Virus Vaccine (H1N1) Sales 2017-2028 (K Doses)
    Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Influenza Virus Vaccine (H1N1) Revenue 2017-2028 (US$ Million)
    Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
    Figure 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2023-2028)
    Figure 17. North America Influenza Virus Vaccine (H1N1) Sales YoY (2017-2028) & (K Doses)
    Figure 18. North America Influenza Virus Vaccine (H1N1) Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Influenza Virus Vaccine (H1N1) Sales YoY (2017-2028) & (K Doses)
    Figure 20. Europe Influenza Virus Vaccine (H1N1) Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales YoY (2017-2028) & (K Doses)
    Figure 22. Asia-Pacific Influenza Virus Vaccine (H1N1) Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Influenza Virus Vaccine (H1N1) Sales YoY (2017-2028) & (K Doses)
    Figure 24. Latin America Influenza Virus Vaccine (H1N1) Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales YoY (2017-2028) & (K Doses)
    Figure 26. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Influenza Virus Vaccine (H1N1) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Influenza Virus Vaccine (H1N1) in the World: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2021
    Figure 29. Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
    Figure 31. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
    Figure 32. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
    Figure 33. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
    Figure 34. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
    Figure 35. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
    Figure 36. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
    Figure 37. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
    Figure 38. North America Influenza Virus Vaccine (H1N1) Sales Share by Country (2017-2028)
    Figure 39. North America Influenza Virus Vaccine (H1N1) Revenue Share by Country (2017-2028)
    Figure 40. U.S. Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
    Figure 43. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
    Figure 45. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Influenza Virus Vaccine (H1N1) Sales Share by Country (2017-2028)
    Figure 47. Europe Influenza Virus Vaccine (H1N1) Revenue Share by Country (2017-2028)
    Figure 48. Germany Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 49. France Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Share by Region (2017-2028)
    Figure 59. China Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 62. India Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Influenza Virus Vaccine (H1N1) Sales Share by Country (2017-2028)
    Figure 74. Latin America Influenza Virus Vaccine (H1N1) Revenue Share by Country (2017-2028)
    Figure 75. Mexico Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Share by Country (2017-2028)
    Figure 84. Turkey Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Influenza Virus Vaccine (H1N1) Revenue (2017-2028) & (US$ Million)
    Figure 87. Influenza Virus Vaccine (H1N1) Value Chain
    Figure 88. Influenza Virus Vaccine (H1N1) Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Vaccine Technologies Market Report Forecast 2022 2028
Global and United States Vaccine Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30Z5715
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Healthcare Acquired Infection Market Report Forecast 2022 2028
Global and United States Healthcare-Acquired Infection Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24Z5686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028
Global and United States Viral Vector Vaccines Market Report & Forecast 2022-2028

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.Market Analysis and Insights Global and United States Viral Vector Vaccines MarketThis report focuses on global and United States Viral Vector Vaccines market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Viral Vector Vaccines market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30G10233
Tue Jun 07 00:00:00 UTC 2022

Add to Cart